Why Do My Chest and Nipples Hurt?

Experiencing pain in the chest and nipples can be distressing, but it’s important to recognize that this symptom has a broad differential diagnosis—ranging from benign, self-limiting conditions to more serious underlying pathologies. Chest wall pain—often described as sharp, localized, or reproducible with palpation—may originate from musculoskeletal sources such as costochondritis, muscle strain, or rib trauma. Nipple tenderness, particularly when bilateral and cyclical, is frequently associated with hormonal fluctuations during the menstrual cycle, pregnancy, or lactation. It may also occur as a side effect of certain medications, including selective serotonin reuptake inhibitors (SSRIs), antipsychotics, or hormonal contraceptives.

However, clinicians must remain vigilant for red-flag features that warrant prompt evaluation. Unilateral, persistent, or progressive nipple pain—especially when accompanied by skin changes (e.g., dimpling, erythema, scaling), nipple discharge (particularly if bloody or spontaneous), or a palpable breast mass—should raise concern for inflammatory breast cancer, ductal carcinoma in situ, or other malignancies. Similarly, chest pain that radiates to the jaw or left arm, is associated with dyspnea, diaphoresis, or syncope, or is triggered by exertion requires urgent cardiac assessment to rule out acute coronary syndrome or other cardiopulmonary emergencies.

Diagnostic evaluation typically begins with a detailed history—including onset, duration, laterality, aggravating or relieving factors, and associated symptoms—followed by a thorough physical examination. Imaging modalities such as mammography, breast ultrasound, or MRI may be indicated based on age, risk factors, and clinical suspicion. Laboratory studies—including serum prolactin, thyroid-stimulating hormone (TSH), and estradiol—can help identify endocrine contributors. Ultimately, management is tailored to the underlying cause: conservative measures for musculoskeletal or hormonal etiologies, targeted pharmacotherapy for medication-induced hyperprolactinemia, or multidisciplinary oncologic intervention when malignancy is confirmed.